{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T09:16:16Z","timestamp":1792314976277,"version":"4.4.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":2842,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1038\/modpathol.2014.120","type":"journal-article","created":{"date-parts":[[2014,9,12]],"date-time":"2014-09-12T12:20:32Z","timestamp":1410524432000},"page":"564-574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma"],"prefix":"10.1016","volume":"28","author":[{"given":"Fatima","family":"Hamadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P","family":"MacNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine S","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven H","family":"Swerdlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2014.120_bib1","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/01.pap.0000184176.65919.17","article-title":"Lymphoplasmacytic lymphoma\/waldenstrom macroglobulinemia: an evolving concept","volume":"12","author":"Lin","year":"2005","journal-title":"Adv Anat Pathol"},{"key":"10.1038\/modpathol.2014.120_bib2","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"194","article-title":"Lymphoplasmacytic Lymphoma","author":"Swerdlow","year":"2008"},{"issue":"Suppl 1","key":"10.1038\/modpathol.2014.120_bib3","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1038\/modpathol.2012.180","article-title":"Nodal and leukemic small B-cell neoplasms","volume":"26","author":"Cook","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2014.120_bib4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1309\/AJCP8FOIVTB6LBER","article-title":"Lymphoplasmacytic lymphoma and other non-marginal zone lymphomas with plasmacytic differentiation","volume":"136","author":"Lin","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2014.120_bib5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0140-6736(74)91786-3","article-title":"Classification of non-Hodgkin's lymphomas","volume":"304","author":"Bennett","year":"1974","journal-title":"Lancet"},{"issue":"suppl","key":"10.1038\/modpathol.2014.120_bib6","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/1097-0142(197410)34:8+<1488::AID-CNCR2820340822>3.0.CO;2-C","article-title":"Immunologic characterization of human malignant lymphomas","volume":"34","author":"Lukes","year":"1974","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2014.120_bib7","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/00000478-200106000-00005","article-title":"Is lymphoplasmacytic lymphoma\/immunocytoma a distinct entity? A clinicopathologic study of 20 cases","volume":"25","author":"Andriko","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2014.120_bib8","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1097\/PAS.0b013e3181758806","article-title":"Fluorescence immunophenotypic and interphase cytogenetic characterization of nodal lymphoplasmacytic lymphoma","volume":"32","author":"Sargent","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2014.120_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cancergencyto.2005.04.013","article-title":"Deletion 6q is not a characteristic marker of nodal lymphoplasmacytic lymphoma","volume":"162","author":"Cook","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1038\/modpathol.2014.120_bib10","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.humpath.2003.10.014","article-title":"Lack of PAX5 rearrangements in lymphoplasmacytic lymphomas: reassessing the reported association with t(9;14)","volume":"35","author":"Cook","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2014.120_bib11","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P Somatic Mutation in Waldenstr\u00f6m's Macroglobulinemia","volume":"367","author":"Treon","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2014.120_bib12","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/leu.2013.62","article-title":"MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenstr\u00f6m's macroglobulinemia","volume":"27","author":"Jim\u00e9nez","year":"2013","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2014.120_bib13","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1182\/blood-2013-04-494849","article-title":"A new era for Waldenstrom macroglobulinemia: MYD88 L265P","volume":"121","author":"Treon","year":"2013","journal-title":"Blood"},{"key":"10.1038\/modpathol.2014.120_bib14","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1182\/blood-2012-06-436329","article-title":"MYD88 L265P mutation in Waldenstrom macroglobulinemia","volume":"121","author":"Poulain","year":"2013","journal-title":"Blood"},{"key":"10.1038\/modpathol.2014.120_bib15","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1182\/blood-2012-09-454355","article-title":"MYD88 L265P in Waldenstr\u00f6m macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction","volume":"121","author":"Xu","year":"2013","journal-title":"Blood"},{"key":"10.1038\/modpathol.2014.120_bib16","doi-asserted-by":"crossref","first-page":"e80088","DOI":"10.1371\/journal.pone.0080088","article-title":"L265P mutation of the MYD88 gene Is frequent in Waldenstr\u00f6m's macroglobulinemia and its absence in myeloma","volume":"8","author":"Mori","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/modpathol.2014.120_bib17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1309\/AJCP10ZCLFZGYZIP","article-title":"MYD88 L265P somatic mutation: its usefulness in the differential diagnosis of bone marrow involvement by B-cell lymphoproliferative disorders","volume":"140","author":"Ondrejka","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2014.120_bib18","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"179","author":"Swerdlow","year":"2008"},{"key":"10.1038\/modpathol.2014.120_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature09671","article-title":"Oncogenically active MYD88 mutations in human lymphoma","volume":"470","author":"Ngo","year":"2011","journal-title":"Nature"},{"key":"10.1038\/modpathol.2014.120_bib20","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1365-2141.2012.09176.x","article-title":"MYD88 somatic mutations in MALT lymphomas","volume":"158","author":"Li","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1038\/modpathol.2014.120_bib21","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1182\/blood-2012-09-457101","article-title":"Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms","volume":"121","author":"Varettoni","year":"2013","journal-title":"Blood"},{"key":"10.1038\/modpathol.2014.120_bib22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/leu.2012.257","article-title":"IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstr\u00f6m macroglobulinemia\/lymphoplasmacytic lymphomas","volume":"27","author":"Gachard","year":"2013","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2014.120_bib23","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMc1211959","article-title":"MYD88 L265P somatic mutation in IgM MGUS","volume":"367","author":"Landgren","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2014.120_bib24","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1109016","article-title":"SF3B1 and other novel cancer genes in chronic lymphocytic leukemia","volume":"365","author":"Wang","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2014.120_bib25","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1182\/blood-2013-12-543306","article-title":"Mutations in the Toll-like receptor\/MYD88 pathway in chronic lymphocytic leukemia identify a subset of young patients with favorable outcome","volume":"123","author":"Mart\u00ednez-Trillos","year":"2014","journal-title":"Blood"},{"key":"10.1038\/modpathol.2014.120_bib26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia","volume":"475","author":"Puente","year":"2011","journal-title":"Nature"},{"key":"10.1038\/modpathol.2014.120_bib27","first-page":"351A","article-title":"MYD88 L265P mutation analysis aids in classifying nodal small B-cell lymphomas","volume":"27","author":"Ho","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2014.120_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hon.993","article-title":"In situ follicular lymphoma: pathologic characteristics and diagnostic features","volume":"30","author":"Carbone","year":"2012","journal-title":"Hematol Oncol"},{"key":"10.1038\/modpathol.2014.120_bib29","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1182\/blood-2011-05-355255","article-title":"Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma","volume":"118","author":"Jegalian","year":"2011","journal-title":"Blood"},{"key":"10.1038\/modpathol.2014.120_bib30","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3324\/haematol.2013.085548","article-title":"Nature and importance of follicular lymphoma precursors","volume":"99","author":"Mamessier","year":"2014","journal-title":"Haematologica"},{"key":"10.1038\/modpathol.2014.120_bib31","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1309\/T88X-71U4-WC0R-2531","article-title":"Assessment of CD10 in the diagnosis of small B-cell lymphomas: a multiparameter flow cytometric study","volume":"117","author":"Xu","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2014.120_bib32","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1046\/j.1440-1827.2001.01277.x","article-title":"Morphological spectrum of cyclin D1-positive mantle cell lymphoma: study of 168 cases","volume":"51","author":"Yatabe","year":"2001","journal-title":"Pathol Int"},{"key":"10.1038\/modpathol.2014.120_bib33","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1182\/blood-2007-07-098848","article-title":"Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity?","volume":"111","author":"Traverse-Glehen","year":"2008","journal-title":"Blood"},{"key":"10.1038\/modpathol.2014.120_bib34","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1365-2559.2002.01314.x","article-title":"Splenic small B-cell lymphoma with predominant red pulp involvement: a diffuse variant of splenic marginal zone lymphoma?","volume":"40","author":"Mollejo","year":"2002","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2014.120_bib35","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"191","article-title":"Splenic B-cell lymphoma\/leukemia, unclassifiable","author":"Piris","year":"2008"},{"key":"10.1038\/modpathol.2014.120_bib36","first-page":"18","article-title":"Non-Hodgkin's lymphoproliferative disorders involving the spleen","volume":"10","author":"Arber","year":"1997","journal-title":"Mod Pathol."},{"key":"10.1038\/modpathol.2014.120_bib37","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/00000478-200308000-00007","article-title":"Waldenstrom macroglobulinemia involving extramedullary sites: morphologic and immunophenotypic findings in 44 patients","volume":"27","author":"Lin","year":"2003","journal-title":"Am J Surg Pathol."},{"key":"10.1038\/modpathol.2014.120_bib38","first-page":"1","article-title":"IgG-lymphoplasmacytic lymphoma following polycythemia vera: JAK2 V617F and MYD88 L265P mutations separated in the same house","volume":"3","author":"Anelli","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1038\/modpathol.2014.120_bib39","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3109\/10428194.2013.831091","article-title":"Lack of MYD88 L265P in non-immunoglobulin M lymphoplasmacytic lymphoma","volume":"55","author":"Manasanch","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1038\/modpathol.2014.120_bib40","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/leu.2013.333","article-title":"On the way towards a \u2018CLL prognostic index\u2019: focus on TP53, BIRC3, SF3B1, NOTCH1 and MYD88 in a population-based cohort","volume":"28","author":"Cortese","year":"2014","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2014.120_bib41","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/leu.2013.263","article-title":"SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients","volume":"28","author":"Jeromin","year":"2014","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2014.120_bib42","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s00277-001-0385-8","article-title":"Waldenstr\u00f6m's macroglobulinemia: clinical course and prognostic factors in 60 patients. Experience from a single hematology unit","volume":"80","author":"Kyrtsonis","year":"2001","journal-title":"Ann Hematol"},{"key":"10.1038\/modpathol.2014.120_bib43","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.humpath.2012.10.026","article-title":"MYD88 expression and L265P mutation in diffuse large B-cell lymphoma","volume":"44","author":"Choi","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2014.120_bib44","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1038\/bcj.2013.28","article-title":"High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites","volume":"3","author":"Kraan","year":"2013","journal-title":"Blood Cancer J"},{"key":"10.1038\/modpathol.2014.120_bib45","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/modpathol.2013.156","article-title":"Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphoma","volume":"27","author":"Pham-Ledard","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2014.120_bib46","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/leu.2013.348","article-title":"High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma","volume":"28","author":"Kraan","year":"2014","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2014.120_bib47","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.humpath.2013.10.023","article-title":"CD79B and MYD88 mutations in diffuse large B-cell lymphoma","volume":"45","author":"Kim","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2014.120_bib48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1309\/AJCP63OGXHXCSKSC","article-title":"Marginal zone lymphomas with plasmacytic differentiation and related disorders","volume":"136","author":"Molina","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2014.120_bib49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.blre.2004.03.002","article-title":"Splenic marginal zone lymphoma","volume":"19","author":"Oscier","year":"2005","journal-title":"Blood Rev"},{"key":"10.1038\/modpathol.2014.120_bib50","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1097\/00000478-200012000-00001","article-title":"Splenic marginal zone lymphoma with or without plasmacytic differentiation","volume":"24","author":"Van Huyen","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2014.120_bib51","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.humpath.2009.09.007","article-title":"Defining the borders of splenic marginal zone lymphoma: a multiparameter study","volume":"41","author":"Dufresne","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2014.120_bib52","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"185","article-title":"Splenic B-cell marginal zone lymphoma","author":"Isaacson","year":"2008"},{"key":"10.1038\/modpathol.2014.120_bib53","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/10245330701445392","article-title":"Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy","volume":"12","author":"Berentsen","year":"2007","journal-title":"Hematology"},{"key":"10.1038\/modpathol.2014.120_bib54","first-page":"460","article-title":"Primary chronic cold agglutinin disease: a population based clinical study of 86 patients","volume":"91","author":"Berentsen","year":"2006","journal-title":"Haematologica"},{"key":"10.1038\/modpathol.2014.120_bib55","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3324\/haematol.2013.091702","article-title":"Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma","volume":"99","author":"Randen","year":"2014","journal-title":"Haematologica"},{"key":"10.1038\/modpathol.2014.120_bib56","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/PAS.0b013e318240590a","article-title":"Gamma heavy-chain disease: defining the spectrum of associated lymphoproliferative disorders through analysis of 13 cases","volume":"36","author":"Bieliauskas","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2014.120_bib57","doi-asserted-by":"crossref","unstructured":"Hamadeh F, MacNamara S, Bacon CM, et al. Gamma heavy chain disease lacks the MYD88 L265P mutation associated with lymphoplasmacytic lymphoma. Haematologica 23 May 2014;e-pub ahead of print","DOI":"10.3324\/haematol.2014.108688"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2014120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2014120","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222014508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222014508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2014120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:49:44Z","timestamp":1760230184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222014508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0893395222014508"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2014.120","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2014.120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}